Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

BACKGROUND: A considerable number of people with multiple sclerosis (pwMS) live in low- and middle-income countries (LMIC), where lack of resource adversely affects access to effective disease-modifying treatment. OBJECTIVE: The objective of this commentary is to propose a useful cost-effective dise...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mult Scler J Exp Transl Clin
Autors principals: Mao, Zhifeng, Álvarez-Gonzalez, César, De Trane, Stefania, Yildiz, Ozlem, Albor, Christo, Doctor, Gabriel, Soon, Derek, Pepper, George, Turner, Benjamin P, Marta, Monica, Mathews, Joela, Giovannoni, Gavin, Baker, David, Schmierer, Klaus
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6077935/
https://ncbi.nlm.nih.gov/pubmed/30090639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318783767
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars